The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.
Jun 7, 2026
0
77
New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced ...
Jun 11, 2026
0
56
An anticancer medication called TLD1433, a ruthenium(II) complex that has entered Phase II trials for conditions such as non-muscle-invasive bladder cancer, is now being repurposed to address one of the biggest public health ...
Influenza is a seasonal condition that causes coughing, sneezing, mild fever and aches in most cases. However, it can sometimes take a serious turn, leading to hospitalization, especially for young children, adults over 65 ...
Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives. However, a small portion of people experience detectable—and worrisome—traces of the virus that causes ...
Jun 8, 2026
0
20
The U.S. Food and Drug Administration has approved Shionogi's Xocova (ensitrelvir), an oral antiviral, for postexposure prophylaxis (PEP) of COVID‑19 in adults and adolescents aged 12 years and older.
Jun 9, 2026
0
16
Following infection, the Ebola virus can survive unnoticed in the human body for months or even years, hiding in areas with little immune surveillance like the central nervous system. The danger is that those affected may ...
Jun 12, 2026
0
15
Persistent symptoms after COVID-19 infection continue to affect millions of people worldwide, even as the number of acute infections has declined. Long COVID (LC) can cause fatigue, headaches, sleep disturbances, breathing ...
Jun 12, 2026
0
9
A looming public health crisis may be spreading from Britain's fields to its hospitals, experts—which include University of Manchester scientists—have warned—with common farm chemicals potentially fueling deadly infections.
Jun 7, 2026
0
8
In a study published in The Lancet, researchers at The University of Texas Medical Branch (UTMB) report the development of new vaccines that, in animal testing, provided full protection against the deadly Andes hantavirus ...
Jun 12, 2026
0
7
